PMC:7294857 / 7578-7978 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":73,"end":106},"obj":"Disease"},{"id":"T40","span":{"begin":123,"end":131},"obj":"Disease"},{"id":"T41","span":{"begin":261,"end":265},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Li T (2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory Syndrome Corona-virus 2 (COVID-19).   A combination of anti-virals Lopinavir/Ritonavir is useful in some cases and can be used as needed. When a patient develops ARDS, A protective ventilation strategy should be used, and when it is severe, the authors recommended extracorporeal membrane oxygenation."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T58","span":{"begin":0,"end":2},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"},{"id":"T59","span":{"begin":114,"end":119},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T60","span":{"begin":137,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T61","span":{"begin":242,"end":243},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T62","span":{"begin":267,"end":268},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T63","span":{"begin":379,"end":387},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"}],"text":"Li T (2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory Syndrome Corona-virus 2 (COVID-19).   A combination of anti-virals Lopinavir/Ritonavir is useful in some cases and can be used as needed. When a patient develops ARDS, A protective ventilation strategy should be used, and when it is severe, the authors recommended extracorporeal membrane oxygenation."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":0,"end":2},"obj":"Chemical"},{"id":"T27","span":{"begin":166,"end":175},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"}],"text":"Li T (2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory Syndrome Corona-virus 2 (COVID-19).   A combination of anti-virals Lopinavir/Ritonavir is useful in some cases and can be used as needed. When a patient develops ARDS, A protective ventilation strategy should be used, and when it is severe, the authors recommended extracorporeal membrane oxygenation."}

{"project":"LitCovid-sentences","denotations":[{"id":"T68","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T69","span":{"begin":237,"end":400},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Li T (2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory Syndrome Corona-virus 2 (COVID-19).   A combination of anti-virals Lopinavir/Ritonavir is useful in some cases and can be used as needed. When a patient develops ARDS, A protective ventilation strategy should be used, and when it is severe, the authors recommended extracorporeal membrane oxygenation."}

{"project":"LitCovid-PubTator","denotations":[{"id":"195","span":{"begin":73,"end":121},"obj":"Species"},{"id":"196","span":{"begin":244,"end":251},"obj":"Species"},{"id":"205","span":{"begin":166,"end":185},"obj":"Chemical"},{"id":"208","span":{"begin":123,"end":131},"obj":"Disease"},{"id":"209","span":{"begin":261,"end":265},"obj":"Disease"}],"attributes":[{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"Tax:2697049"},{"id":"A196","pred":"tao:has_database_id","subj":"196","obj":"Tax:9606"},{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"MESH:C558899"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"MESH:C000657245"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Li T (2020) Recommendation To give comprehensive recommendations about Severe Acute Respiratory Syndrome Corona-virus 2 (COVID-19).   A combination of anti-virals Lopinavir/Ritonavir is useful in some cases and can be used as needed. When a patient develops ARDS, A protective ventilation strategy should be used, and when it is severe, the authors recommended extracorporeal membrane oxygenation."}